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The threat of zoonotic transmission of infectious
agents at monkey temples highlights the necessity of inves-
tigating the prevalence of enzootic infectious agents in
these primate populations. Biological samples were collect-
ed from 39 rhesus macaques at the Swoyambhu Temple
and tested by enzyme-linked immunosorbent assay,
Western blot, polymerase chain reaction, or combination of
these tests for evidence of infection with rhesus
cytomegalovirus (RhCMV), Cercopithecine herpesvirus 1
(CHV-1), simian virus 40 (SV40), simian retrovirus (SRV),
simian T-cell lymphotropic virus (STLV), simian immunode-
ficiency virus (SIV), and simian foamy virus (SFV). Antibody
seroprevalence was 94.9% to RhCMV (37/39), 89.7% to
SV40 (35/39), 64.1% to CHV-1 (25/39), and 97.4% to SFV
(38/39). Humans who come into contact with macaques at
Swoyambhu risk exposure to enzootic primateborne virus-
es. We discuss implications for public health and primate
management strategies that would reduce contact between
humans and primates.
M
ost pathogens that affect humans are thought to have
originated in animals and subsequently evolved to
successfully parasitize human populations (1). Proximity
and physical contact between animals and humans provide
the opportunity for infectious agents to pass between the
groups. Whether a particular infectious agent can success-
fully make the cross-species jump depends in part on the
new host environment (1). By virtue of their genetic, phys-
iologic, and behavioral similarity to humans, nonhuman
primates (hereafter referred to as primates) are particularly
likely sources of emerging infectious agents with the
capacity to infect humans, and primate-to-human cross-
species transmission of infectious agents has become a
focus of scientific inquiry. Because human-primate contact
is common in Asia, this continent is a rich area in which to
pursue this research. We examine the prevalence of select-
ed enzootic primateborne viruses in a population of rhesus
macaques (Macaca mulatta) that lives in close proximity
to humans.
Monkey Temple Context for 
Cross-species Transmission
Monkey temples can be found throughout South and
Southeast Asia, where primates play a role in Hindu and
Buddhist culture (2). Macaque species, because they can
thrive in human-altered environments, are the primates
most often associated with temples. Extensive, unregulat-
ed, and often close contact between humans and primates
occurs at these sites (3). Persons who live or work in or
around monkey temples are among those who frequently
come into contact with temple monkeys (4). Other persons
may come into contact with temple macaques when they
visit for purposes of worship, recreation, or tourism.
Worldwide, monkey temples may account for more
human-primate contact than any other context (5).
Swoyambhu Temple is 1 of 2 temple sites in the dense-
ly populated Kathmandu valley with a large population of
free-ranging rhesus monkeys (6) (Figure 1). As 1 of the
region’s oldest and most important Buddhist holy places,
Swoyambhu has been designated a world heritage site and
continues to play a vibrant role in Kathmandu’s cultural
life. In addition to the Tibetan monks, Brahmin priests, and
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Antonio, Texas, USANewar nuns who live on the site, a brisk flow of local wor-
shipers and visitors from around the world passes through
Swoyambhu. Persons who live and work in and around
Swoyambhu share common water sources with the
macaques and report that the macaques frequently invade
their homes and gardens in search of food. The macaques at
Swoyambhu have become a tourist attraction in their own
right, and many visitors interact with the monkeys, often by
feeding or teasing them (Figure 2). A growing literature
documents human-macaque interactions at monkey tem-
ples in Asia (2–5). Macaques climb on the heads and shoul-
ders of visitors, which may bring macaque body fluids into
contact with visitors’ eyes and nasal and oral mucosa,
potential portals of entry for infectious agents. Visitors may
also be bitten or scratched by macaques during aggressive
encounters, resulting in transcutaneous exposure to infec-
tious agents present in macaque body fluids.
Enzootic Simian Viruses
Cercopithecine herpesvirus 1
Cercopithecine herpesvirus 1 (CHV-1), also known as
herpes B virus, is a member of the taxonomic subfamily
Alphaherpesviridae. Serologic evidence of infection with
CHV-1 has been documented in several species of
macaques (7). Seroprevalence of anti-herpesvirus antibod-
ies is 10%–80% among wild populations and can reach
100% among captive populations, though the percentage
of infected monkeys who shed virus at a given time is only
1%–2% (8).
While CHV-1 infection in primates is almost always
benign, CHV-1 infection in humans causes severe menin-
goencephalitis with a death rate approaching 70% (9).
Several routes of primate-to-human transmission have
been implicated, most involving direct exposure to tissue
or fluid from an infected macaque. One case of human-to-
human transmission of CHV-1 has been documented (10).
No cases of CHV-1 infection have been documented in
persons exposed to free-ranging macaques, in spite of a
long history of human-macaque commensalism in Asia.
SV40
Simian virus 40 (SV40) is a polyomavirus enzootic
among some species of Asian macaques, including rhesus
macaques of northern India and Nepal. SV40 is present in
the genitourinary tract of infected macaques and is thought
to be transmitted through ingestion of urine containing the
virus (11). SV40 first became an object of public health
interest in the 1960s when millions of doses of polio vac-
cine, produced in tissue cultures of monkey kidney cells,
were contaminated with SV40. Shah (12) examined the
seroprevalence of antibodies to polyomavirus among
workers at 2 monkey export firms in India who had abun-
dant, long-term contact with rhesus macaques; he found a
seroprevalence of 27% among these workers and noted
that SV40 seroprevalence increased with duration of work
in the export firms. Recent technological advances have
improved the specificity of immunoassays that detect anti-
bodies to SV40 (13). Using these new methods, Engels and
colleagues reported evidence of human SV40 infection
among zoo employees who worked with primates (14).
Rhesus Cytomegalovirus
Rhesus cytomegalovirus (RhCMV), Cercopithecine
herpesvirus 8, is a β-herpesvirus enzootic among M.
mulatta, infecting up to 100% of rhesus macaques >1 year
of age in breeding populations of captive animals (15). In
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Figure 1. Swoyambhu Temple in Kathmandu, Nepal, is home to
400 free-ranging rhesus macaques (Macaca mulatta). (Photo by
R. Kyes.)
Figure 2. Rhesus macaques at Swoyambhu Temple routinely get
food handouts from local inhabitants and visitors. (Photo by L.
Jones-Engel.)immunologically intact animals, RhCMV infections are
asymptomatic. RhCMV can cause illness and death in rhe-
sus macaques co-infected with immunosuppressive retro-
viruses (simian type D retrovirus and simian
immunodeficiency virus) (16) or in experimentally infect-
ed rhesus macaque fetuses (17). Infection is lifelong, with
continued viral shedding from mucosal surfaces (18).
Though growth of RhCMV in human cells has been
demonstrated in vitro, human infection with RhCMV has
yet to be reported (19).
Enzootic Simian Retroviruses
Macaques harbor several enzootic retroviruses, includ-
ing simian foamy virus (SFV), simian type D retrovirus
(SRV), and simian T-cell lymphotropic virus (STLV). SRV
and SFV are present in saliva and other body fluids of
infected macaques, which suggests that bites, scratches,
and mucosal splashes with macaque body fluids can trans-
mit infection (20,21). Previous studies examining labora-
tory and zoo workers as well as bushmeat hunters in Africa
and monkey temple workers in Indonesia have shown that
humans can be infected with SFV and SRV (5,22–24).
STLV is closely related to human T-cell lymphotropic
virus (HTLV-1). Asymptomatic infection with STLV-1 is
common among primate hosts. STLV is hypothesized to be
the progenitor of HTLV through multiple cross-species
transmissions (25).
Simian immunodeficiency virus (SIV) is widely dis-
tributed among African primates and has been shown to
infect humans who come into contact with them (26).
Though SIV has not, to date, been detected among Asian
primates, several species of Asian macaques have been
experimentally infected with the virus (27). And though
international trade in primates is regulated by the
Convention on International Trade in Endangered Species,
illicit import and export of primates continues, potentially
exposing Asian primates to infectious agents, such as SIV,
that are enzootic among African primate species.
Materials and Methods
Macaque Population
The rhesus macaques at Swoyambhu number ≈400, dis-
tributed among 5 to 7 groups with overlapping home
ranges (6). Physical contact among macaque groups is
common. Natural forage is extremely limited at
Swoyambhu (Figure 3). Almost all of the macaques’ daily
food comes from handouts given by persons who frequent
the temple site.
Field Methods
During a 4-day period in May 2003, a total of 39
macaques from 3 different groups (12 from group 1, 11
from group 2, and 16 from group 3) were trapped, sampled,
and released. Samples were obtained as part of a compre-
hensive health screening effort conducted at the request of
the Federation of Swoyambhu Management and
Conservation Committee. Macaques were trapped in a
portable cage measuring 2.5 × 2.5 × 1.5 m and sedated with
3 mg/kg intramuscular tiletamine HCl/zolazepam HCl. To
avoid stressing young animals, infants were not anaes-
thetized or sampled as part of this protocol. All anesthetized
macaques were given a complete physical examination, and
using universal precautions and sterile technique, we col-
lected 10 mL blood by venipuncture of the femoral vein; 8
mL blood was centrifuged to extract serum. The remaining
blood was aliquotted into Vacutainer vials containing
EDTA. Unique study identification numbers were assigned
to all specimens collected from each animal. Serum and
whole blood were frozen in the field, then stored at −70°C.
Animals were tattooed on their inner right thigh for identi-
fication and future follow-up. Each macaque’s weight and
dental formula were collected and recorded for age assess-
ment. Age was estimated on the basis of observed dental
eruption sequence. After sample collection, animals were
placed in a cage and allowed to recover fully from anesthe-
sia before being released as a group back into their home
range. This data collection protocol was reviewed and
approved by the University of Washington Institutional
Animal Care and Use Committee (#3143-03).
Laboratory and Data Analysis Methods
After necessary national and international permits were
obtained, the samples were shipped to the United States,
where they were analyzed at several institutions. Enzyme
immunoassays for anticapsid antibodies to SV40 were per-
formed as described previously (13). Serologic status to
RhCMV was determined by enzyme-linked immunosor-
bent assay (ELISA) with an infected cell extract to detect
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Figure 3. Natural forage is extremely limited at Swoyambhu.
Rhesus macaques routinely raid garbage bins and people's
homes in search of food.  (Photo by R. Kyes.)RhCMV-specific immunoglobulin G (IgG) (28). ELISAs
were used to detect antibodies to SRV, STLV, SIV, and
CHV-1 as previously described (29,30). Because of
endogenous seroreactivity to retroviral proteins in
macaques, immunoblot assays for STLV and SRV
serotypes 1, 2, 4, and 5 and were performed on all samples
to confirm antibody status. Reactions were deemed posi-
tive if core and envelope bands were present, indetermi-
nate if only core or only envelope were present, and
negative if bands did not appear or were lighter than those
for negative control plasma. Real-time polymerase chain
reaction (PCR) for SRV was performed as previously
described (30). To produce large volumes of SRV-1, 2, 4,
and 5 antigens for enzyme immunoassay, infected cell
supernatants were collected, concentrated, and purified on
sucrose gradients as previously described (29). Nested
PCR to detect STLV in these samples was performed as
previously described (30). Western blot immunoassays for
SFV were performed as previously described, with a few
modifications (5,31).
Demographic and serologic data were entered into a
spreadsheet, and univariate analysis was performed with
the JUMP-IN 4 statistical software package (SAS Institute,
Inc., Cary, NC, USA). Statistical associations between
macaque viral seropositivity, sex, age class, and group
number were determined by χ2 test.
Results
Table 1 presents the demographic distribution of the
macaques sampled. The animals sampled may not reflect
the demographic breakdown of the Swoyambhu popula-
tion as a whole because animals were trapped opportunis-
tically, and infants were excluded from the study.
Approximately 9.75% of Swoyambhu’s estimated
macaque population was sampled. Table 2 presents sero-
prevalence data for the 39 macaques sampled. Seven sam-
ples reacted to SRV on ELISA; 4 of these 7 were
indeterminate on immunoblot, and 3 were negative.
Repeated attempts to amplify SRV from all samples,
including those indeterminate by immunoblot, by using
PCR primers in 2 different regions of the genome were not
successful. STLV testing showed 9 samples to be reactive
on ELISA, but none were confirmed positive by
immunoblot. Nested PCR did not detect STLV DNA in
peripheral blood mononuclear cells. Additional tests for
SRV and STLV by PCR were performed to rule out latent
virus in genomic DNA, since some apparent false reactiv-
ity was seen on ELISA and Western blot. None of the 39
serum samples was reactive on SIV ELISA.
The results of the serologic and PCR assays were ana-
lyzed by using χ2 to test associations by sex, group num-
ber, and age category. The results from these tests show no
significant association between seropositivity for antibod-
ies to RhCMV, SV40, or SFV and age, sex, or group num-
ber of the macaque. However, a significant (χ2 p<0.0001)
age-related effect was seen for CHV-1. Seroprevalence of
antibodies to CHV-1 increased from 23.1% (3/13) among
juveniles to 100% (19/19) among adult macaques.
Discussion
Relatively little is known about enzootic primate virus-
es in free-ranging populations of macaques. CHV-1 anti-
body prevalence has been measured among temple
monkeys in Bali (4), rhesus monkeys (M. mulatta) from
India (32), and free-ranging rhesus monkeys transplanted
to the Caribbean Island of Cayo Santiago (11). The CHV-
1 seroprevalence among these populations is similar to that
of the Swoyambhu macaques, with a similar positive asso-
ciation between age and seroprevalence. SFV prevalence
among the Bali macaques was also similar to that meas-
ured in the Swoyambhu macaques (5). The high seropreva-
lence of RhCMV in the Swoyambhu macaque population
mirrors that measured in other studies that assessed sero-
prevalence in both captive and free-ranging populations of
macaques and other primates (15,33).
Evidence of STLV-1 infection was not found among the
Swoyambhu macaques with either serologic or PCR detec-
tion methods. In comparison, a survey measuring STLV-1
prevalence among wild-caught M. fascicularis in
Indonesia by serologic methods and PCR suggested an
STLV prevalence between 3.3% and 10% (34), and a sam-
ple of wild-caught M. fascicularis from 9 localities in
Thailand were all antibody-negative for STLV-1 (35).
No conclusive serologic or PCR evidence of SRV
infection was found among the Swoyambhu macaques.
SRV infection is commonly seen among laboratory pri-
mates, but far less so among other free-ranging primate
populations examined to date (L. Jones-Engel, unpub.
data). Increased population densities characteristic of cap-
tive settings may facilitate viral transmission, providing a
possible explanation for this observation.
The absence of SIV in the Swoyambhu macaque popu-
lation is unsurprising, given that SIV has yet to be detect-
ed in natural populations of Asian primates. This finding,
however, does not eliminate the possibility that the situa-
tion could change in the future. While SIV is typically
found only among African primates, this virus could be
introduced into Asian primate populations through the
global market trade in animals, in which pet primates can
Temple Monkeys and Implications of Commensalism
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seen in monkey forests in Asia, and future surveys of Asian
primates should continue to test for SIV.
Public Health Implications
A growing literature suggests that cross-species trans-
mission of infectious agents occurs between humans and
several primate species in a variety of contexts and in
diverse areas (4,5,22–24,37,38). Indeed, wherever humans
and primates come into contact, the potential for cross-
species transmission exists. Whether cross-species trans-
mission occurs depends on several factors, including the
prevalence of infectious agents in primate reservoirs, the
context of interspecies contact, and the frequency with
which contact occurs (39). To date, cross-species transmis-
sion has been most thoroughly studied in primate laborato-
ries and zoos because of the ready availability of biological
samples from both primates and exposed humans
(14,22,23,40). Research on humans exposed to primates in
these contexts has documented an SFVseroconversion rate
of 1% to 5.3%, an SV40 seroconversion rate of 3% to 10%,
and an SRV rate of 0.9%. Human CHV-1 infection is rare
and has only been documented among persons directly or
indirectly exposed to laboratory primates (9).
The dynamics of human-macaque contact at Asian
monkey temples differ substantially from those in labora-
tories and zoos, which may make cross-species transmis-
sion more likely at monkey temples. Because primate
laboratories have been promoting specific pathogen-free
colonies, the risk for primate-to-human transmission of
enzootic agents in these settings is likely to diminish over
time. Additionally, primate laboratories require the routine
use of eye protection, gloves, and protective garments.
Injury protocols call for thorough irrigation of wounds and
close follow-up of exposed persons. In contrast, research
examining wound care practices among exposed workers
at the Sangeh monkey forest in Bali (4) found no use of
protective eyewear, gloves, or protective clothing.
Bleeding wounds from macaque scratches and bites were
often not cleansed, and only 6 of 51 persons bitten or
scratched by a macaque sought medical care (4). As a
result, exposure to bites, scratches, and mucosal splashes
at monkey temples may carry a higher risk for primate-to-
human viral transmission than does exposure in primate
laboratories and zoos.
From a global infection control standpoint, learning
about primate-to-human transmission at monkey temples
like Swoyambhu is particularly relevant. Because the num-
ber of humans who come into contact with primates at
monkey temples around the world is probably several mil-
lion per year (3), monkey temples are an important inter-
face between humans and primates. Additionally, many of
the visitors to Swoyambhu are foreign tourists, which
makes Swoyambhu a potential point source for the global
dispersal of infectious agents, as world travelers can return
to their homes carrying novel infectious agents transmitted
from macaques. Monkey temples of South and Southeast
Asia are also near large human population centers. The
combination creates the potential for rapid global dispersal
of primateborne infectious agents to human populations
around the world.
In spite of centuries of human-primate commensalism
in Asia, human disease has yet to be causally linked to
enzootic primateborne viruses. However, disease may go
undetected because of low incidence, inadequate surveil-
lance, and lack of awareness. Latency between infection
and disease manifestation could mask the association
between primate exposure and disease. Though long-term
commensalism may lead to increased immunity to pri-
mateborne pathogens among exposed human populations,
non-Asian visitors might be vulnerable, and increased
travel to Asia would expose more nonimmune persons to
primateborne pathogens. Finally, as HIV continues to
spread in Asia, increasing numbers of immunosuppressed
persons will likely be exposed to primateborne infectious
agents. Immunocompromised hosts could provide
pathogens a “permissive” environment in which to evolve
into more pathogenic forms.
Management Strategies
In taking steps to reduce the risk for cross-species trans-
mission between humans and primates, we should first
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conditions, and behavior that lead to contact and transmis-
sion. Because feeding macaques is thought to account for
most interactions between humans and macaques, adopt-
ing protocols to restrict feeding to persons specifically
trained for that purpose could reduce the number of visi-
tors who come into direct contact with macaque body flu-
ids. Educating visitors as well as persons who live near
monkey temples to avoid behavior that leads to bites and
scratches could reduce risk. Finally, availability and
awareness of proper protocol for effective wound irriga-
tion has the potential to reduce transmission of infection.
No data on the efficacy of postexposure prophylaxis with
antiviral agents are available, but pharmacologic therapy is
another tool that could reduce the likelihood of cross-
species viral transmission. In addition, monitoring human
populations for infection with primate viruses at the
human-primate interface is a prudent strategy to facilitate
the early detection of primateborne zoonoses.
This information must be put into context. The recent
culling of macaques at a wildlife park in England and at
monkey temples in Hong Kong and Taiwan in response to
the perceived threat of zoonotic transmission of CHV-1 is
an example of an exaggerated response to an inadequately
understood risk. Improving awareness of zoonotic trans-
mission and effective management strategies among the
public as well as among persons who manage primate
parks and temples will be instrumental in allowing humans
and primates to continue to coexist.
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